Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
Authors:
- 1 January 2009
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (2) , 397-400
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Drug development of MET inhibitors: targeting oncogene addiction and expedienceNature Reviews Drug Discovery, 2008
- c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related MutationsJournal of Biological Chemistry, 2008
- Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applicationsExpert Opinion on Therapeutic Patents, 2007
- Covalent Assembly of Molecular LaddersJournal of the American Chemical Society, 2007
- c-Met as a target for human cancer and characterization of inhibitors for therapeutic interventionCancer Letters, 2005
- c-Met: Structure, functions and potential for therapeutic inhibitionCancer and Metastasis Reviews, 2003
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252aProceedings of the National Academy of Sciences, 2003
- Scope and Limitations of the Pd/BINAP-Catalyzed Amination of Aryl BromidesThe Journal of Organic Chemistry, 2000
- Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond FormationAccounts of Chemical Research, 1998